Authors
Richard J Caselli, Jessica Langbaum, Gary E Marchant, Rachel A Lindor, Katherine S Hunt, Bruce R Henslin, Amylou C Dueck, Jason S Robert
Publication date
2014/10/1
Journal
Mayo Clinic Proceedings
Volume
89
Issue
10
Pages
1389-1396
Publisher
Elsevier
Description
Objective
To explore the self-expressed desire for, envisioned reaction to, and basic understanding of presymptomatic Alzheimer disease (AD)–related genetic and biomarker tests.
Patients and Methods
The Alzheimer’s Prevention Registry is an online community of people at least 18 years of age who are interested in AD prevention research for purely informational purposes or to be considered for possible research participation in future studies. Information about presymptomatic testing and an online multiple choice format survey were posted from November 1, 2012, through June 20, 2013, on the registry website.
Results
Of 4036 respondents, 80.8% (3195/3952) wanted genetic testing if paid by insurance and 58.7% (2261/3851) if it would cost them at least $100. A total of 80.2% (3112/3879) wanted biomarker testing. If at high risk for AD, 90.5% (3478/3841) endorsed that they would “pursue a healthier lifestyle …
Total citations
201520162017201820192020202120222023202435695498146
Scholar articles
RJ Caselli, J Langbaum, GE Marchant, RA Lindor… - Mayo Clinic Proceedings, 2014